PHILIPS EV300 Trilogy Clinical and Caregiver Addendum Instructions
- June 1, 2024
- Philips
Table of Contents
Clinical & Caregiver
Manual Addendum
EV300 Trilogy Clinical and Caregiver Addendum
Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal, & Trilogy EV300
This addendum applies to the Trilogy Evo platform and the Clinical and
Caregiver manuals. The following sections are supplemental to those manuals.
Contraindications
- The AVAPS-AE therapy mode is contraindicated for invasive use and patients less than 10 kg.
- The AVAPS feature is contraindicated for patients less than 10 kg.
Bluetooth Antenna Separation Distance
This product meets RF exposure requirements when it is positioned with a
separation distance of at least 20 cm away from the body.
Note: The Bluetooth® word mark and logos are registered trademarks owned
by Bluetooth SIG, Inc. and any use of such marks by Philips Respironics is
under license.
Respironics Inc.
1001 Murry Ridge Lane
Murrysville, PA 15668 USA
Respironics Deutschland GmbH & Co. KG
Gewerbestrasse 17
82211 Herrsching, Germany
0123
1147302
1147302 R09
LB 02/23/2023